Impact of UCSF criteria according to pre- and post-OLT tumor features: Analysis of 479 patients listed for HCC with a short waiting time

Liver Transplantation

Volumn 12, Issue 12, 2006, Pages 1761-1769

  Decaens, Thomas ^a   Roudot Thoraval, Françoise ^a   Hadni Bresson, Solange ^b   Meyer, Carole ^c   Gugenheim, Jean ^d   Durand, Francois ^e   Bernard, Pierre Henri ^f   Boillot, Olivier ^g   Sulpice, Laurent ^h   Calmus, Yvon ⁱ   Hardwigsen, Jean ^j   Ducerf, Christian ^k   Pageaux, Georges Philippe ^l   Dharancy, Sebastien ^m   Chazouilleres, Olivier ⁿ   Cherqui, Daniel ^a   Duvoux, Christophe ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^c HÔPITAL DE HAUTEPIERRE   (France)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^e BEAUJON HOSPITAL   (France)

^f HÔPITAL PELLEGRIN   (France)

^g EDOUARD HERRIOT HOSPITAL   (France)

^h PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

ⁱ Hôpital Cochin ^*  (France)

^j HÔPITAL DE LA CONCEPTION   (France)

^k CROIX ROUSSE HOSPITAL   (France)

^l HÔPITAL SAINT ELOI   (France)

^m LILLE UNIVERSITY HOSPITAL   (France)

ⁿ HÔPITAL SAINT ANTOINE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; LYMPHOCYTE ANTIBODY; MEPREDNISONE;

ADULT; ALCOHOL ABUSE; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEATH; ECHOGRAPHY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH CARE ORGANIZATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PATIENT CODING; PATIENT SELECTION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TIME; TREATMENT INDICATION; TUMOR VOLUME; VALIDITY;

EID: 33845482284     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20884     Document Type: Article

References (14)

1. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
2. Figueras J, Jaurrieta E, Valls C, Benasco C, Rafecas A, Xiol X, et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 1997;25:1485-1489.
3. Llovet JM, Bruix J, Fuster J, Castells A, Garcia-Valdecasas JC, Grande L, et al. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology 1998;27:1572-1577.
4. Herrero JI, Sangro B, Quiroga J, Pardo F, Herraiz M, Cienfuegos JA, Prieto J. Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl 2001;7:631-636.
5. Yoo HY, Part CH, Geschwind JF, Thuluvath PJ. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol 2003;21:4329-4335.
6. Marsh JW, Dvorchik I. Liver organ allocation for hepatocellular carcinoma: are we sure? Liver Transpl 2003;9:693-696.
7. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-1403.
8. Kneteman NM, Oberholzer J, Al Saghier M, Meeberg GA, Blitz M, Ma MM, et al. Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma. Liver Transpl 2004; 10:1301-1311.
9. Broelsch CE, Frilling A, Malago M. Should we expand the criteria for liver transplantation for hepatocellular carcinoma - yes, of course! J Hepatol 2005;43:569-573.
10. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649.
11. Karnofsky DA. Palliation and life prolongation with anti-cancer drugs. CA Cancer J Clin 1966;16:117-119.
12. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24:289-293.
13. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999;30: 1434-1440.
14. American Liver Tumor Study Group. A randomized prospective multiinstutional trial of orthotopic liver transplantation or partial hepatic resection with or without adjuvant chemotherapy for hepatocellular carcinoma. In: Investigator Booklet and Protocol; 1998.